| Symbol | Name | Allocation | Country | Exchange |
|---|---|---|---|---|
| CSL | CSL Limited | 2.83% | AU | ASX |
| PTCT | PTC Therapeutics, Inc. | 2.63% | US | NASDAQ |
| RARE | Ultragenyx Pharmaceutical Inc. | 2.61% | US | NASDAQ |
| SGEN | Seattle Genetics, Inc. | 2.59% | US | NASDAQ |
| TVTX | Travere Therapeutics, Inc. | 2.26% | US | NASDAQ |
| EBS | Emergent Biosolutions, Inc. | 1.75% | US | NYSE |
| BSLN | Basilea Pharmaceutica AG | 1.25% | CH | SW |
| CUV | Clinuvel Pharmaceuticals Limited | 1.15% | AU | ASX |